Esperion Therapeutics: Of The Original Report To Present The Required Financial Statements And Pro Forma Financial Information Not Later Than 71 Calendar Days From The Date On Which The Original Report Was Required To Be Filed, As Permitted Under Items 9.01(a)(3) And 9.01(b)(2). Except For The Filing Of Such Financial Statements And Pro Forma Financial Information, This Amendment Does Not Otherwise Modify Or Update The Original Report, And This Amendment Should Be Read In Conjunction With The Original Report

Mostra articolo completo

Questa funzionalità è disponibile solo per gli utenti registrati

• Nome completo dell'emittente
  Esperion Therapeutics, Inc.
• Paese di registrazione
  USA
• Settore industriale
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***